Similar articles for PMID: 23704316

Year	Number of Results
1981	1
1995	1
1996	3
1998	1
1999	2
2000	1
2001	1
2002	1
2003	2
2004	3
2005	8
2006	10
2007	8
2008	9
2009	3
2010	2
2011	3
2012	2
2013	6
2014	7
2015	4
2016	8
2017	5
2018	4
2019	1
2020	3
2021	2
2022	4
2024	0

1

Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.

Michel L, Vukusic S, De Seze J, Ducray F, Ongagna JC, Lefrère F, Jacq-Foucher M, Confavreux C, Wiertlewski S, Laplaud DA. Michel L, et al. J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):279-83. doi: 10.1136/jnnp-2013-305298. Epub 2013 May 23. J Neurol Neurosurg Psychiatry. 2014. PMID: 23704316

2

Mycophenolate mofetil in the treatment of multiple sclerosis: a preliminary report.

Pandit L, Mustafa S, Malli C, D'Cunha A. Pandit L, et al. Neurol India. 2014 Nov-Dec;62(6):646-8. doi: 10.4103/0028-3886.149390. Neurol India. 2014. PMID: 25591678 Free article. Clinical Trial.

3

Efficacy and safety of mycophenolate mofetil in progressive multiple sclerosis patients.

Fakih R, Matiello M, Chitnis T, Stankiewicz JM. Fakih R, et al. J Neurol. 2018 Nov;265(11):2688-2694. doi: 10.1007/s00415-018-9050-1. Epub 2018 Sep 10. J Neurol. 2018. PMID: 30203314

4

Efficacy and safety of mycophenolate mofetil therapy in neuromyelitis optica spectrum disorders: a systematic review and meta-analysis.

Songwisit S, Kosiyakul P, Jitprapaikulsan J, Prayoonwiwat N, Ungprasert P, Siritho S. Songwisit S, et al. Sci Rep. 2020 Oct 7;10(1):16727. doi: 10.1038/s41598-020-73882-8. Sci Rep. 2020. PMID: 33028926 Free PMC article.

5

Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: A prospective cohort study.

Xu Y, Wang Q, Ren HT, Qiao L, Zhang Y, Fei YY, Zhao Y, Cui LY. Xu Y, et al. J Neurol Sci. 2016 Nov 15;370:224-228. doi: 10.1016/j.jns.2016.09.035. Epub 2016 Sep 21. J Neurol Sci. 2016. PMID: 27772764

6

Mycophenolate mofetil for relapsing-remitting multiple sclerosis.

Xiao Y, Huang J, Luo H, Wang J. Xiao Y, et al. Cochrane Database Syst Rev. 2014 Feb 7;2014(2):CD010242. doi: 10.1002/14651858.CD010242.pub2. Cochrane Database Syst Rev. 2014. PMID: 24505016 Free PMC article. Review.

7

The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China.

Chen H, Zhang Y, Shi Z, Feng H, Yao S, Xie J, Zhou H. Chen H, et al. Clin Neuropharmacol. 2016 Mar-Apr;39(2):81-7. doi: 10.1097/WNF.0000000000000131. Clin Neuropharmacol. 2016. PMID: 26818042

8

Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.

Owen C, Ngian GS, Elford K, Moore O, Stevens W, Nikpour M, Rabusa C, Proudman S, Roddy J, Zochling J, Hill C, Sturgess A, Tymms K, Youssef P, Sahhar J. Owen C, et al. Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):170-176. Epub 2016 Mar 24. Clin Exp Rheumatol. 2016. PMID: 27049330

9

Mycophenolate mofetil in multiple sclerosis.

Frohman EM, Brannon K, Racke MK, Hawker K. Frohman EM, et al. Clin Neuropharmacol. 2004 Mar-Apr;27(2):80-3. doi: 10.1097/00002826-200403000-00006. Clin Neuropharmacol. 2004. PMID: 15252268

10

Mycophenolate mofetil for the treatment of scleritis.

Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR. Sen HN, et al. Ophthalmology. 2003 Sep;110(9):1750-5. doi: 10.1016/S0161-6420(03)00570-0. Ophthalmology. 2003. PMID: 13129873 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year